
Loading, please wait...

Loading, please wait...

As space agencies worldwide, including India’s ISRO with the Gaganyaan mission, prepare for long-duration travel, understanding physiological changes in microgravity is critical. Spaceflight-Associated Neuro-Ocular Syndrome (SANS) remains a top concern for medical teams. This condition typically manifests as optic disc edema and expansion of the brain’s ventricular volume. A recent study published in JAMA Ophthalmology addressed whether astronauts flying multiple missions face an increased risk of worsening structural changes.
The research compared structural changes between a first and second exposure to either spaceflight or head-down tilt bed rest (HDTBR), a common terrestrial analog. Investigators used optical coherence tomography (OCT) to measure peripapillary total retinal thickness (TRT). Magnetic resonance imaging (MRI) was also employed to quantify lateral ventricular volume (LVV) expansion. Surprisingly, the study found that repeat exposure did not significantly augment the magnitude of change for either metric.
Specifically, the mean difference in retinal thickness between missions was negligible. Furthermore, brain ventricular expansion remained consistent across subsequent exposures. Consequently, these findings suggest that the acute physiological response to microgravity may not have a cumulative structural effect on these specific tissues during a second mission. However, medical experts emphasize that the potential for long-term functional changes remains a subject for further investigation.
For clinicians involved in aerospace medicine, these results provide a framework for predicting physiological shifts in multi-mission crewmembers. Monitoring remains essential, as individual variability in SANS development is high. Moreover, the use of terrestrial analogs like HDTBR continues to be a valid method for studying these phenomena. Future research will likely focus on whether recovery intervals between missions influence these structural outcomes.
SANS is characterized by optic disc edema, posterior globe flattening, choroidal folds, and hyperopic refractive shifts. It is primarily observed during long-duration spaceflight missions.
According to recent case series data, a second exposure to spaceflight or bed rest does not appear to significantly increase the magnitude of optic disc edema or brain ventricular expansion compared to the first exposure.
The expansion of brain ventricles in microgravity is thought to be related to cephalad fluid shifts and changes in cerebrospinal fluid resorption. Understanding this expansion is vital for assessing long-term neurological health.
Disclaimer: This content is for informational and educational purposes only and does not constitute medical advice. It is not intended to be a substitute for professional medical advice, diagnosis, or treatment. Refer to the latest local and national guidelines for clinical practice.
References
Carter KJ et al. Repeat Exposures to Spaceflight or Bed Rest and Spaceflight-Associated Neuro-Ocular Syndrome Findings. JAMA Ophthalmol. 2026 Jun 18. doi: 10.1001/jamaophthalmol.2026.2140. PMID: 42313423.
NASA. Spaceflight Associated Neuro-Ocular Syndrome (SANS) Evidence Report. 2024. Available from: https://www.nasa.gov/
Laurie SS et al. Optic Disc Edema and Brain Volumetrics in Astronauts. JAMA Ophthalmol. 2020;138(2):165-172.

Read summarized clinical updates, watch expert medical content, and earn CME certifications right from your smartphone.


A recent study investigates whether repeat exposure to spaceflight or bed rest increases the severity of Spaceflight-Associated Neuro-Ocular Syndrome (SANS), finding no significant cumulative effect on optic disc edema or brain ventricular volume expansion across multiple missions.
2 months ago

The phase 3 ACACIA-HCM trial reveals that aficamten improves cardiac structure, diastolic relaxation, functional capacity, and symptom burden in symptomatic nonobstructive hypertrophic cardiomyopathy, marking a major milestone in targeted myosin inhibition.
Last week

A clinical study shows that automated breast ultrasound paired with artificial intelligence accurately classifies BIRADS 3-4 lesions, reaching 95% sensitivity and 79% specificity. This diagnostic advance promises to reduce unnecessary core needle biopsies and refine clinical workflows in breast imaging.
4 weeks back

Researchers have engineered freestanding hierarchical-porous BCZT thin films that resist cracking and enhance ultrasonic energy harvesting in soft tissue. Achieving high piezoelectric output and acoustic matching, this lead-free material offers transformative potential for implantable bioelectronics.
Last week

A novel pathology-adaptive surface engineering strategy uses functionalized plasma polymer coatings to selectively modulate AGE adsorption, reducing oxidative stress and restoring bone formation in diabetic and aging microenvironments.
4 weeks back

A breakthrough study identifies the Klotho/PKCα/CUX1/SPARC/TGFβ-RII axis as a critical driver of podocyte mitochondrial injury and ferroptosis in diabetic kidney disease, unveiling promising molecular targets to halt renal disease progression.
Last week